Showing promise in the arena of weight management treatment, retatrutide represents a unique strategy. Different from many existing medications, retatrutide works as a twin agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) receptors. This concurrent activation fosters multiple advanta… Read More